SEC Form 4 · accession 0001645627-17-000123
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 26, 2017
Accepted (ET)
Sep 28, 2017 · 2:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 26, 2017 | P | 5,000 | $0.0449 | A | 23,551,189 | D | |
| Common Stock | Sep 26, 2017 | P | 5,000 | $0.0429 | A | 23,556,189 | D | |
| Common Stock | Sep 26, 2017 | P | 5,000 | $0.0445 | A | 23,561,189 | D | |
| Common Stock | Sep 26, 2017 | P | 5,000 | $0.0445 | A | 23,566,189 | D | |
| Common Stock | Sep 26, 2017 | P | 5,000 | $0.045 | A | 23,571,189 | D | |
| Common Stock | Sep 27, 2017 | P | 3,000 | $0.0435 | A | 23,574,189 | D | |
| Common Stock | Sep 27, 2017 | P | 5,000 | $0.0435 | A | 23,579,189 | D | |
| Common Stock | Sep 27, 2017 | P | 3,000 | $0.0427 | A | 23,582,189 | D | |
| Common Stock | Sep 27, 2017 | P | 3,000 | $0.0427 | A | 23,585,189 | D | |
| Common Stock | Sep 27, 2017 | P | 5,000 | $0.0427 | A | 23,590,189 | D | |
| Common Stock | Sep 27, 2017 | P | 3,000 | $0.0435 | A | 23,593,189 | D | |
| Common Stock | Sep 27, 2017 | P | 3,000 | $0.0435 | A | 23,596,189 | D | |
| Common Stock | Sep 27, 2017 | P | 3,000 | $0.0435 | A | 23,599,189 | D | |
| Common Stock | Sep 27, 2017 | P | 3,000 | $0.0439 | A | 23,602,189 | D | |
| Common Stock | Sep 27, 2017 | P | 3,000 | $0.044 | A | 23,605,189 | D | |
| Common Stock | Sep 27, 2017 | P | 3,000 | $0.044 | A | 23,608,189 | D |
Table II — derivative securities
No Table II lines on this filing.